Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | 18964387627 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Talastine | C19H21N3O | 16188-61-7 | Details |
| UCM-13207 | C24H32N2O2 | 1621536-10-4 | Details |
| (R)-AZD 9639 | C21H15ClN4O2 | 1646857-28-4 | Details |
| Isolupalbigenin | C25H26O5 | 162616-70-8 | Details |
| AC 7739 | C18H21NO4.ClH | 162705-22-8 | Details |
| JG-231 | C22H18BrCl2N3OS4 | 1627126-59-3 | Details |
| Karavilagenin F | C31H50O5 | 1639024-15-9 | Details |
| Aprutumab | 1634620-63-5 | Details |
| BTA-9881 | C21H15ClN4O2 | 1646857-24-0 | Details |
| UniPR129 | C36H52N2O4 | 1639159-47-9 | Details |
| Delmetacin | C18H15NO3 | 16401-80-2 | Details |
| Inotuzumab | 1660159-36-3 | Details |
| GBT1118 | C19H20N2O4 | 1628799-51-8 | Details |
| Zilovertamab | 1643432-38-5 | Details |
| Leramistat | C20H21ClN2O3S | 1642602-54-7 | Details |
| Itacnosertib | C26H28N8O | 1628870-27-8 | Details |
| CRT-0105950 | C21H16ClN3OS | 1661845-86-8 | Details |
| TL4-12 | C25H27F3N6O2 | 1620820-12-3 | Details |
| Ralaniten triacetate | C27H33ClO8 | 1637573-04-6 | Details |
| Ranevetmab | 1632282-27-9 | Details |
| Tavolixizumab | 1635395-25-3 | Details |
| Honokiol DCA | C22H18Cl4O4 | 1620160-42-0 | Details |
| Gü2602 | C16H22N4O3 | 1627094-88-5 | Details |
| (Rac)-Telinavir | C33H44N6O5 | 162679-88-1 | Details |
| MAO-B-IN-8 | C18H16O6 | 1638956-60-1 | Details |
| GNE-8505 | C21H24F3N5O | 1620573-48-9 | Details |
| KZR-504 | C21H23N3O6 | 1629052-78-3 | Details |
| TASP0390325 | C25H30Cl2FN5O4 | 1642187-96-9 | Details |
| (R)-DNMDP | C15H20N4O3 | 1630760-60-9 | Details |
| Ladiratuzumab | 1629760-28-6 | Details |
| TDRL-551 | C25H23ClIN3O4 | 1644626-43-6 | Details |
| TAK-020 | C18H17N5O3 | 1627603-21-7 | Details |
| Zectivimod | C28H31Cl2N3O3 | 1623066-63-6 | Details |
| Talviraline | C15H20N2O3S2 | 163451-80-7 | Details |
| Parthenosin | C25H26O13 | 166196-16-3 | Details |
| SLMP53-1 | C20H18N2O2 | 1643469-17-3 | Details |
| Naratuximab | 1622327-39-2 | Details |
| Vonlerolizumab | 1638935-72-4 | Details |
| Flotetuzumab | 1664355-28-5 | Details |
| Suvratoxumab | 1629620-18-3 | Details |
| Tomuzotuximab | 1646321-00-7 | Details |
| HTL14242 | C16H8ClFN4 | 1644645-32-8 | Details |
| MLK-IN-1 | C23H20N4O3S | 1627729-62-7 | Details |
| Fluoroethylnormemantine hydrochloride | C12H21ClFN | 1639210-25-5 | Details |
| (Rac)-Naxifylline | C18H24N4O3 | 166181-76-6 | Details |
| Dalzanemdor | C27H43F3O2 | 1629853-48-0 | Details |
| pan-HER-IN-2 | C19H15BrClN5O | 1639040-95-1 | Details |
| hTYR/AbTYR-IN-1 | C18H20N2O3 | 1625821-37-5 | Details |
| BDBM50597431 | 1629853-49-1 | Details |
| Nerelimomab | 162774-06-3 | Details |
| Dapson-13C12 | C12H12N2O2S | 1632119-29-9 | Details |
| NDB | C26H28Cl2N2O2 | 1660153-08-1 | Details |
| ALDH2 modulator 1 | C18H18ClFN2O3 | 1629615-99-1 | Details |
| Selicrelumab | 1622140-49-1 | Details |
| Fluoroethylnormemantine | C12H20FN | 1639210-26-6 | Details |
| ZEN-3694 | C19H19N5O | 1643947-30-1 | Details |
| Clivatuzumab | 1622075-09-5 | Details |
| 3-(Piperidin-4-yl)benzo[d]oxazol-2(3H)-one hydrochloride | C12H15ClN2O2 | 162045-54-7 | Details |
| Rivabazumab | 1627519-84-9 | Details |
| Suptavumab | 1629615-23-1 | Details |
| Lupartumab | 1640971-88-5 | Details |
| Relatlimab | 1673516-98-7 | Details |
| PW0464 | C19H17F2N3O4 | 1643462-93-4 | Details |
| (Rac)-MEM 1003 | C22H25ClN2O5 | 165187-25-7 | Details |
| AGN 192870 | C27H22O2 | 166977-57-7 | Details |
| Azido-PEG3-C6-Cl | C12H24ClN3O3 | 1625717-44-3 | Details |
| BrBzGCp2 | C27H38BrN3O6S | 166038-00-2 | Details |
| L-372662 | C33H38N4O6 | 162045-26-3 | Details |
| VU0453379 | C26H34N4O2 | 1638646-27-1 | Details |
| PDK1-IN-RS2 | C15H9ClN2O2S3 | 1643958-89-7 | Details |
| Timigutuzumab | 1665274-14-5 | Details |
| Cipepofol | C14H20O | 1637741-58-2 | Details |
| Nav1.8-IN-4 | C20H14F4N2O3 | 1620846-16-3 | Details |
| DA-6886 | C19H28Cl2N6O2 | 1645260-76-9 | Details |
| Glycopyrronium tosylate | C26H35NO6S | 1624259-25-1 | Details |
| GPR81 agonist 1 | C22H30N4O2S2 | 1620992-67-7 | Details |
| GS-626510 | C25H22N4O | 1637770-13-8 | Details |
| Laprituximab | 1622327-38-1 | Details |
| Frovocimab | 1643672-70-1 | Details |
| DI-82 | C20 H26 N6 O4 S3 | 1638148-50-1 | Details |
| Osimertinib-d6 | C28H33N7O2 | 1638281-44-3 | Details |
| CT-2584 | C30H55N5O3 | 166981-13-1 | Details |
| FGFR4-IN-5 | C23H23Cl2N5O5 | 1628793-01-0 | Details |
| ACT-660602 | C20H20F6N8OS | 1646267-59-5 | Details |
| DHODH-IN-17 | C12H9ClN2O2 | 16344-26-6 | Details |
| Eptinezumab | 1644539-04-7 | Details |
| Fremanezumab | 1655501-53-3 | Details |
| Enrasentan | C29H30O8 | 167256-08-8 | Details |
| ABI-1968 | C35H58N5O6P | 1626364-18-8 | Details |
| Otilimab | 1638332-55-4 | Details |
| Navicixizumab | 1638338-43-8 | Details |
| TGP-377/421 | C20H16N6 | 16752-89-9 | Details |
| Ibiglustat succinate | C24H30FN3O6S | 1629063-80-4 | Details |
| Vobarilizumab | 1628814-88-9 | Details |
| URAT1 inhibitor 7 | C19H10ClFN4O3S | 1632002-28-8 | Details |
| FD-IN-1 | C23H23NO4 | 1646682-14-5 | Details |
| Gimsilumab | 1648796-29-5 | Details |
| Elsubrutinib | C17H19N3O2 | 1643570-24-4 | Details |
| CPL304110 | C25H30N6O2 | 1627826-19-0 | Details |
| RS1-PDK1 inhibitor | C15H9ClN2O2S3 | 1643958-85-3 | Details |
| Product Total： Product Page： | ||||
| 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||